Adhd attention deficit hyperactivity disorder Treatment Tracking Results
All information is based on patient-tracked and shared data. A behavior disorder in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Three types include predominately inattentive, predominately hyperactive impulsive, and combined behaviors.
Stats
|
Element |
# Stacks |
|
Taken for |
|
Fish Oil
|
27
|
|
Adhd Attention Deficit Hyperactivity Disorder (27), Generalized Anxiety Disorder (22), and more.
|
|
Alpha GPC
|
26
|
|
Adhd Attention Deficit Hyperactivity Disorder (26), Generalized Anxiety Disorder (15), and more.
|
|
L-Theanine
|
26
|
|
Generalized Anxiety Disorder (32), Adhd Attention Deficit Hyperactivity Disorder (26), and more.
|
|
Magnesium
|
25
|
|
Adhd Attention Deficit Hyperactivity Disorder (25), Generalized Anxiety Disorder (22), and more.
|
|
Adderall
|
16
|
|
Adhd Attention Deficit Hyperactivity Disorder (16), Generalized Anxiety Disorder (9), and more.
|
|
Caffeine
|
15
|
|
Generalized Anxiety Disorder (22), Adhd Attention Deficit Hyperactivity Disorder (15), and more.
|
|
Vitamin D
|
14
|
|
Generalized Anxiety Disorder (19), Adhd Attention Deficit Hyperactivity Disorder (14), and more.
|
|
Noopept
|
13
|
|
Generalized Anxiety Disorder (16), Adhd Attention Deficit Hyperactivity Disorder (13), and more.
|
|
Bacopa monnieri
|
12
|
|
Adhd Attention Deficit Hyperactivity Disorder (12), Generalized Anxiety Disorder (7), and more.
|
|
Aniracetam
|
11
|
|
Adhd Attention Deficit Hyperactivity Disorder (11), Generalized Anxiety Disorder (5), and more.
|
Popular stacks with this condition
Locations
|
Location |
# Users |
|
|
Canada
|
57
|
|
|
United States
|
49
|
|
|
Estonia
|
17
|
|
|
United Kingdom
|
3
|
|
|
ETC/GMT 12
|
2
|
|
|
GMT
|
1
|
|
Age & Gender
|
Age Group |
# Users |
|
|
< 20
|
2
|
|
|
20s
|
15
|
|
|
30s
|
7
|
|
|
40s
|
4
|
|
|
50s
|
0
|
|
|
60s
|
0
|
|
|
70s
|
0
|
|
|
Not Reported
|
81
|
|
5+ Users with condition
